Annual Accounts Payable
$2.61 M
+$1.44 M+123.65%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual accounts payable is $2.61 million, with the most recent change of +$1.44 million (+123.65%) on December 31, 2023.
- During the last 3 years, DNTH annual accounts payable has risen by +$1.25 million (+92.05%).
- DNTH annual accounts payable is now at all-time high.
Performance
DNTH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.57 M
+$3.88 M+104.93%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly accounts payable is $7.57 million, with the most recent change of +$3.88 million (+104.93%) on September 30, 2024.
- Over the past year, DNTH quarterly accounts payable has increased by +$6.20 million (+453.10%).
- DNTH quarterly accounts payable is now at all-time high.
Performance
DNTH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DNTH Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.7% | +453.1% |
| 3 y3 years | +92.0% | +453.1% |
| 5 y5 years | +92.0% | +453.1% |
DNTH Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.7% | at high | +548.8% |
| 5 y | 5-year | at high | +123.7% | at high | +548.8% |
| alltime | all time | at high | +123.7% | at high | +548.8% |
Dianthus Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.57 M(+104.9%) |
| Jun 2024 | - | $3.69 M(+41.5%) |
| Mar 2024 | - | $2.61 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.61 M(+123.7%) | $2.61 M(+90.7%) |
| Sep 2023 | - | $1.37 M(+17.3%) |
| Dec 2022 | $1.17 M(-14.1%) | $1.17 M |
| Dec 2021 | $1.36 M | - |
FAQ
- What is Dianthus Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual accounts payable year-on-year change?
- What is Dianthus Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly accounts payable year-on-year change?
What is Dianthus Therapeutics annual accounts payable?
The current annual accounts payable of DNTH is $2.61 M
What is the all time high annual accounts payable for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual accounts payable is $2.61 M
What is Dianthus Therapeutics annual accounts payable year-on-year change?
Over the past year, DNTH annual accounts payable has changed by +$1.44 M (+123.65%)
What is Dianthus Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DNTH is $7.57 M
What is the all time high quarterly accounts payable for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly accounts payable is $7.57 M
What is Dianthus Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DNTH quarterly accounts payable has changed by +$6.20 M (+453.10%)